首页> 外文期刊>Contemporary Clinical Trials Communications >Evaluation of the Music Engagement Program for people with Alzheimer's disease and dementia: Study protocol for a pilot trial
【24h】

Evaluation of the Music Engagement Program for people with Alzheimer's disease and dementia: Study protocol for a pilot trial

机译:针对阿尔茨海默氏病和痴呆症患者的音乐参与计划的评估:试点研究方案

获取原文
       

摘要

BackgroundAlzheimer's disease and dementia are prevalent conditions globally. People with Alzheimer's disease and dementia commonly experience mental health problems, negative emotional states, and behavioural disturbance. Music therapy has previously been used in this population to improve symptoms of mental health problems; however, there is a paucity of evidence-based programs that also explore positive outcomes such as overall quality of life, social outcomes, as well as the acceptability and sustainability of these programs.AimsThis project aims to evaluate the effectiveness of the specialised Music Engagement Program (MEP) in improving quality of life, wellbeing, and depression symptoms, in aged-care residents with Alzheimer's disease and dementia. The project also aims to explore how the MEP could be applied and maintained on a broader level throughout the aged-care community.MethodsThe intervention will take place over 8 weeks in an aged-care facility for people living with dementia in Canberra, Australia. Weekly 45-60-min group singing sessions will be led by a music facilitator.ResultsThe results of the study will be submitted for publication in relevant academic journals and mental health conferences, disseminated to participants on request, to the residential care facility, and via the lead researcher's website.ConclusionsThis study can provide an indication of the feasibility of the MEP in enhancing the mental health and wellbeing of individuals with Alzheimer's disease and dementia. Further investigation will be required to establish the MEP's ability to be maintained on an ongoing basis with minimal costs and administrative support.Trial registrationAustralian New Zealand Clinical Trial Registry (ANZCTR): ACTRN12618001690246.
机译:背景阿尔茨海默氏病和痴呆症是全球普遍存在的疾病。患有阿尔茨海默氏病和痴呆症的人通常会遇到心理健康问题,负面的情绪状态和行为障碍。音乐疗法先前已用于该人群中,以改善精神健康问题的症状。但是,缺乏基于证据的计划,也没有探索积极的成果,例如总体生活质量,社会成果以及这些计划的可接受性和可持续性。目的该项目旨在评估专业音乐参与计划的有效性(MEP)改善患有阿尔茨海默氏病和痴呆症的老年护理患者的生活质量,幸福感和抑郁症状。该项目还旨在探索如何在整个老年人护理社区中更广泛地应用和维持MEP。方法干预将在澳大利亚堪培拉的老年痴呆症患者养老机构中进行,为期8周。每周45-60分钟的小组演唱会由音乐主持人主持。研究结​​果将提交至相关学术期刊和心理健康会议上,以应要求分发给参与者,并分发给住宿护理机构,并通过结论本研究可为MEP改善阿尔茨海默氏病和痴呆症患者的心理健康和福祉提供参考。需要进行进一步的调查以建立MEP的持续维护能力,同时保持最低的成本和行政支持。试验注册澳大利亚新西兰临床试验注册中心(ANZCTR):ACTRN12618001690246。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号